# Fibrolamellar Carcinoma: A Rare Liver Neoplasm

**Authors:** Elily D Apumayta, Aaron Kahlam, Eloy F Ruiz

PMC · DOI: 10.7759/cureus.59006 · 2024-04-25

## TL;DR

This paper presents five cases of fibrolamellar carcinoma, a rare liver cancer in young patients, focusing on their treatment and outcomes.

## Contribution

The study contributes a case series highlighting clinical features and recurrence rates after liver resection in young fibrolamellar carcinoma patients.

## Key findings

- Median age of diagnosis was 24 years with nonspecific symptoms in otherwise healthy patients.
- 60% of patients experienced recurrence within one year after hemihepatectomy.
- Classical imaging and histological features were observed in all cases.

## Abstract

Fibrolamellar carcinoma is a rare liver tumor, with most cases arising in people younger than 40 years of age. We present a case series of five patients with histological confirmation of fibrolamellar carcinoma who had liver resection as the primary treatment. The median age of diagnosis was 24 years with nonspecific clinical manifestations in otherwise healthy patients. Alpha-fetoprotein levels were widely variable. Patients had classical imaging, macroscopic, and microscopic findings. Most of our patients underwent a hemihepatectomy and 60% recurred after the first year.

## Linked entities

- **Diseases:** fibrolamellar carcinoma (MONDO:0006210)

## Full-text entities

- **Genes:** AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}
- **Diseases:** Liver Neoplasm (MESH:D008113), Fibrolamellar Carcinoma (MESH:C537258)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11127726/full.md

---
Source: https://tomesphere.com/paper/PMC11127726